Biomark Diagnostics Inc (BUX.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | BUX.CN | ||||
| Company | Biomark Diagnostics Inc | ||||
| Price Information | |||||
| Exchange | CNSX | ||||
| Open | 0.5500 | ||||
| High | 0.5500 | ||||
| Low | 0.5500 | ||||
| Latest | 0.5500 | ||||
| Change | unch | ||||
| % Change | unch | ||||
| Volume | 1,500 | ||||
| 20-Day Average Volume | 9,445 | ||||
| Previous Close | 0.5500 | ||||
| Industry | N/A | ||||
| Has Options | No | ||||
| Technicals | |||||
| 20-Day Moving Average | 0.5275 | ||||
| 20-Day Raw Stochastic | 61.54% | ||||
| 20-Day Relative Strength | 58.25 | ||||
| Weighted Alpha | +141.01 | ||||
| Today's Opinion | 100% Buy | ||||
| Previous Opinion | 100% Buy | ||||
| Last Month's Opinion | 100% Buy | ||||
| Performance | |||||
| 5-Days | |||||
| %Chg | -3.51% since 02/20/26 | ||||
| Low | 0.5300 on 02/26/26 | ||||
| High | 0.6000 on 02/24/26 | ||||
| 1-Month | |||||
| %Chg | +10.00% since 01/27/26 | ||||
| Low | 0.4700 on 02/03/26 | ||||
| High | 0.6000 on 02/24/26 | ||||
| 3-Month | |||||
| %Chg | +52.78% since 11/27/25 | ||||
| Low | 0.3600 on 11/28/25 | ||||
| High | 0.6000 on 02/24/26 | ||||
| 6-Month | |||||
| %Chg | +71.88% since 08/27/25 | ||||
| Low | 0.2700 on 10/03/25 | ||||
| High | 0.6000 on 02/24/26 | ||||
| Key Statistics | |||||
| Market Capitalization, $K | 57,800 | ||||
| Shares Outstanding, K | 105,090 | ||||
| Annual Sales | 154,216 | ||||
| Annual Net Income | -1,927,280 | ||||
| Last Quarter Sales | 6,871 | ||||
| Last Quarter Net Income | -481,393 | ||||
| 60-Month Beta | -0.96 | ||||
| Per-Share Information | |||||
| Most Recent Earnings | -0.01 on 11/28/25 | ||||
| Latest Earnings Date | N/A | ||||
| Most Recent Dividend | N/A | ||||
| Next Ex-Dividends Date | N/A | ||||
| Ratios | |||||
| Price/Earnings ttm | N/A | ||||